Global Next-Generation Sequencing (NGS) Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027
"Global Next-Generation Sequencing (NGS) Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2027” is a recent report generated by MarketResearch.biz, which offers in-depth insights, revenue details, and other vital information regarding the global next-generation sequencing (NGS) market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global next-generation Sequencing (NGS) market report has been segmented on the product & services, technology, application, end-user, and region.
This report is based on synthesis, analysis, and interpretation of information gathered regarding the target market from various sources. Our analysts have analyzed the information and data and gained insights using a mix of primary and secondary research efforts with the primary objective to provide a holistic view of the market. In addition, an in-house study has been made of the global economic conditions and other economic indicators and factors to assess their respective impact on the market historically, as well as the current impact in order to make informed forecasts about the scenarios in future.
Next-generation sequencing also referred as massively parallel sequencing is a non-Sanger-based high-throughput DNA sequencing method used to determine a portion of nucleotide sequence of an individual’s genome. By using next-generation sequencing researchers can rapidly sequence whole genomes, utilize RNA sequencing (RNA-Seq) to discover splice sites and novel RNA variants, analyze epigenetic factors such as DNA-protein interactions and genome-wide DNA methylation and, etc.
Increasing application in clinical diagnosis and genomics research is a major factor driving growth of the global next-generation sequencing (NGS) market. In addition, increasing collaborations and partnerships among major players so as to develop technologically advance next-generation sequencing systems is another factor expected to further fuel growth of the global market to a significant extent during the forecast period. For instance, in April 2018, Illumina, Inc. and Loxo Oncology announced a global strategic partnership, to developing next-generation sequencing-based pan-cancer companion diagnostics.
Budget concerns related to adoption of next-generation sequencing systems, especially in developing countries is a major factor restraining growth of the global market. In addition, lack of skilled professionals coupled with legal and ethical limitation related to next generation sequencing are other factors hampering growth of the global market.
The North America market dominates the global next-generation sequencing (NGS) market in terms of revenue and is expected to maintain its dominance during the forecast period. Presence of major players, rising application of next-generation sequencing in genomics research, and increasing investments are major factors driving growth of North America next-generation sequencing (NGS) market. The Europe market accounts for second highest share in terms of revenue in the global market. The Europe Next-Generation Sequencing (NGS) Market is expected to witness moderate growth and is expected to register a CAGR of X.X% over the forecast period. The Asia Pacific next-generation sequencing (NGS) market is expected to witness highest growth in terms of revenue in the global market and is projected to register a CAGR of XX.X% during the forecast period.
Global Next-Generation Sequencing (NGS) Market Segmentation:
Segmentation on the basis of product & services:
Segmentation on the basis of technology:
- Whole Genome Sequencing
- Whole Exome Sequencing
- RNA Sequencing
- Targeted Re-sequencing
Segmentation on the basis of application:
- Drug Discovery
- Personalized Medicine and Genetic Screening
- Disease Diagnosis
- Agriculture and Animal Research
Segmentation on the basis of end-user:
- Academic institutes & research centres
- Hospitals & clinics
- Pharmaceutical & biotechnology companies
Segmentation on the basis of region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2020 Estimated Year 2021 Forecast Period 2021–2030 Revenue in US$
- Thermo Fisher Scientific Inc.
- BioMerieux S.A.
- Agilent Technologies, Inc.
- Hoffmann-La Roche AG
- Qiagen N.V.
- Illumina, Inc.
- Oxford Nanopore Technologies, Ltd.
- Beijing Genomics Co. Ltd.
- Beckman Coulter (A Subsidiary of Danaher)
- Pacific Biosciences of California, Inc.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!